Furthermore, when doubling the value of Ang-2, the odds of a patient exhibiting F3 or F4 fibrosis stage before antiviral treatment increased by 4.19 times (95% CI 1.55–14.34, p < 0.001). Here, ANGPT2 is linked to fibrosis.